Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Riluzole for PTSD: Efficacy of a Glutamatergic Modulator as Augmentation Treatment for Posttraumatic Stress Disorder

NCT02155829 is registered in ClinicalTrials.gov with Uniformed Services University of the Health Sciences as lead sponsor.

NCT NCT02155829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02155829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Riluzole for PTSD: Efficacy of a Glutamatergic Modulator as Augmentation Treatment for Posttraumatic Stress Disorder
Lead sponsor
Uniformed Services University of the Health Sciences
Phase
Phase 1/2
Overall status
Completed
Start date
July 31, 2013
Completion date
November 30, 2017
Enrollment
75 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ptsd